The objective of this study was to explore the association between plasma neurofilament light chain (pNfL) concentration and disease activity in patients with CIDP and examine the potential usefulness of pNfL concentration as an available axonal biomarker in determining disease activity or remission. This evidence concerns the gene NEFL and chronic inflammatory demyelinating polyradiculoneuropathy.